Lifeboat Foundation

Scientists have designed a test they believe is the first of its kind. Using blood and urine samples, the test correctly identified autism in children.

The new approach could one day allow people to screen themselves for the risks that could lead to heart disease.

Sanming, a city of about 2.5m people in eastern China’s Fujian province, has shown one way out of the conundrum — switching from premium drugs made by multinationals to cheaper local generics and cracking down on doctors taking kickbacks from distributors.

Cheaper drugs cut burden on Sanming budget, but locals grumble over quality of care.

Longevity become hottest object for investments;

Startup founded 5 moths ago just raised $250 million.

The start-up, which launched in September and is headquartered in Warren, N.J., announced Thursday it has raised $250 million in venture capital from global biopharmaceutical company Celgene, biotechnology company United Therapeutics Corporation, biopharmaceutical company Sorrento Therapeutics, DNA sequencing and machine learning company Human Longevity, Inc.

Continue reading “Will 100 be the new 60? Stem cell start-up that raised $250 million could extend lifespan” »

Advance brings us closer to growing transplant organs inside animals or being able to genetically tailor compatible organs, say researchers.

Nicola Davis in Austin.

Summary: A new treatment that uses extracellular vesicles filled with exosomes derived from human stem cells could help repair brain damage following stroke, researchers report.

Source: University of Georgia.

A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.

Artificial Intelligence has come a long way in the last decade and still, you have to ask; Where Are We Today? In reviewing the Brief History of AI or Artificial Intelligence we see such things as Humans VS Machines Chess Champions, but the current research goes way beyond that.

The applications and uses for artificially intelligent machines are endless. Prediction software can help us in medicine, environmental monitoring, weather warnings and even streamlining our transport systems, monetary economic flows and assist us in protecting our nation. The road ahead for artificial intelligence is more like the runway ahead and you can expect us to blast off into the future within the next five years.

For instance, if you are concerned that your CEO is making too much money in your corporation, you need not worry much longer because very soon they will be replaced with an artificial business tool; that’s right, meet your new CEO.

Continue reading “Artificial Intelligence Possible Concepts — Are You Ready for the Future” »

A new ultrathin elastic display that fits snugly on the skin can show the moving waveform of an electrocardiogram recorded by a breathable, on-skin electrode sensor. Combined with a wireless communication module, this integrated biomedical sensor system, called “skin electronics,” can transmit biometric data to the cloud.

This latest research by a Japanese academic-industrial collaboration, led by Professor Takao Someya at the University of Tokyo’s Graduate School of Engineering, is slated for a news briefing and talk at the AAAS Annual Meeting in Austin, Texas on February 17th.

Thanks to advances in semiconductor technology, wearable devices can now monitor health by measuring vital signs or taking an electrocardiogram, and then transmitting the data wirelessly to a smartphone. The readings or electrocardiogram waveforms can be displayed on the screen in real time, or sent to the cloud or a memory device where the information is stored.

Continue reading “Japanese researchers develop ultrathin, highly elastic skin display” »

Researchers at UT Southwestern Medical Center have developed a CRISPR technique to efficiently correct the function of heart cells in patients with Duchenne muscular dystrophy (DMD). It involves making a single cut at strategic points along patient’s DNA, with the team claiming their new approach has the potential to correct most of the 3,000 mutations that cause DMD.

Duchenne muscular dystrophy (DMD) is one of nine neuromuscular disorders that affect the strength of muscles and nerves, specifically caused by defects in the gene that makes the dystrophin protein. Typically, one in every 3,500 boys born will be diagnosed with the disease at around three to four years of age, with their ability to walk gradually decreasing until they reach young adolescence. Most patients live until their 30s, but will require a wheelchair and respirator as the muscles in vital organs deteriorate over time.